Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Cash Flow from Operations

Amag Pharmaceuticals Cash Flow from Operations Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Amag Pharmaceuticals Cash Flow from Operations for the quarter ending June 06, 2020 was $3m a 392.99% increase of 12m year over year
  • Amag Pharmaceuticals Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-73m a -78.61% increase of 57m year over year
  • Amag Pharmaceuticals Annual Cash Flow from Operations for 2019 was $-126m a 148.37% decrease of -186m from 2018
  • Amag Pharmaceuticals Annual Cash Flow from Operations for 2018 was $61m a -75.32% decrease of -46m from 2017
  • Amag Pharmaceuticals Annual Cash Flow from Operations for 2017 was $107m a -130.99% decrease of -140m from 2016
Other Cash Flow Metrics:
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-31m a 66.13% decrease of -21m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Cash Flow from Operations Data

06/2020$3m
03/2020$-47m
12/2019$-20m
09/2019$-9m
06/2019$-7m
03/2019$-90m
12/2018$-24m
09/2018$59m
03/2018$46m
12/2017$70m

Annual AMAG Cash Flow from Operations Data

2019$-126m
2018$61m
2017$107m
2016$246m
2015$96m
2014$11m
2013$-7m
2012$-1m
2011$-64m
2010$-2m